Selpercatinib in Chinese Patients with RET-fusion-positive Non-Small-cell Lung Cancer: Updated Efficacy and Safety Analysis from the Randomized LIBRETTO-321 Phase II Trial
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY(2025)
Key words
central nervous system metastasis,Chinese population,long-term follow-up,non-small-cell lung cancer,selpercatinib
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined